MAIA vs MRNA · $56.9M cap vs rev $145.0M
MAIA Biotechnology Inc. (MAIA) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
MAIA Biotechnology Inc. (MAIA) is a biotechnology company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Latest reported MAIA revenue for 2024-12-31 was $0. Net income was -$23.3M. MAIA currently screens at market cap $56.9M.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
MAIA currently screens at market cap $56.9M. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the MAIA and MRNA stock pages for the full models.
Not investment advice.